Merav Bar

4.6k total citations
50 papers, 1.8k citations indexed

About

Merav Bar is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Merav Bar has authored 50 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 23 papers in Hematology and 15 papers in Molecular Biology. Recurrent topics in Merav Bar's work include CAR-T cell therapy research (17 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Acute Myeloid Leukemia Research (11 papers). Merav Bar is often cited by papers focused on CAR-T cell therapy research (17 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Acute Myeloid Leukemia Research (11 papers). Merav Bar collaborates with scholars based in United States, Brazil and South Africa. Merav Bar's co-authors include David G. Maloney, Cameron J. Turtle, Jerald P. Radich, Jenna Voutsinas, Alexandre V. Hirayama, Ana Cordeiro, Evandro D. Bezerra, Qian Wu, Joshua A. Hill and Muneesh Tewari and has published in prestigious journals such as Blood, Cell stem cell and The Journal of Infectious Diseases.

In The Last Decade

Merav Bar

47 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Merav Bar United States 20 893 606 442 361 303 50 1.8k
Jonathan D. Fish United States 17 985 1.1× 467 0.8× 199 0.5× 476 1.3× 362 1.2× 32 1.6k
Qian Wu United States 20 1.3k 1.5× 489 0.8× 422 1.0× 419 1.2× 311 1.0× 123 2.0k
Cecilia C.S. Yeung United States 18 1.3k 1.4× 392 0.6× 379 0.9× 365 1.0× 317 1.0× 81 2.0k
Tim Sauer Germany 17 734 0.8× 378 0.6× 237 0.5× 326 0.9× 251 0.8× 50 1.1k
Daria Pagliara Italy 21 638 0.7× 277 0.5× 678 1.5× 685 1.9× 202 0.7× 65 1.7k
Manabu Kawakami Japan 24 447 0.5× 1.1k 1.9× 548 1.2× 461 1.3× 74 0.2× 50 1.8k
Rayne H. Rouce United States 17 1.6k 1.7× 554 0.9× 206 0.5× 924 2.6× 488 1.6× 54 2.0k
Francesca Del Bufalo Italy 20 478 0.5× 330 0.5× 155 0.4× 269 0.7× 182 0.6× 78 1.2k
Hai Cheng China 18 485 0.5× 345 0.6× 361 0.8× 268 0.7× 159 0.5× 88 1.2k
Jordan Gauthier United States 20 1.4k 1.6× 375 0.6× 345 0.8× 454 1.3× 335 1.1× 112 2.0k

Countries citing papers authored by Merav Bar

Since Specialization
Citations

This map shows the geographic impact of Merav Bar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merav Bar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merav Bar more than expected).

Fields of papers citing papers by Merav Bar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merav Bar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merav Bar. The network helps show where Merav Bar may publish in the future.

Co-authorship network of co-authors of Merav Bar

This figure shows the co-authorship network connecting the top 25 collaborators of Merav Bar. A scholar is included among the top collaborators of Merav Bar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merav Bar. Merav Bar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oriol, Albert, Roman Hájek, Ivan Špıčka, et al.. (2024). Nivolumab, Pomalidomide, and Elotuzumab Combination Regimens for Treatment of Relapsed and Refractory Multiple Myeloma: Results from the Phase 3 CheckMate 602 Study. Clinical Lymphoma Myeloma & Leukemia. 24(10). 703–714.
2.
Bar, Merav, Mohammed Toufiq, Darawan Rinchai, et al.. (2023). Neutrophil Activation Is a Diagnostic and Candidate Prognostic Biomarker of Acute GvHD. Blood. 142(Supplement 1). 2186–2186. 1 indexed citations
3.
Bar, Merav, Susan M. Ott, E. Michael Lewiecki, et al.. (2020). Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation. 26(10). 1784–1802. 10 indexed citations
4.
Mullane, Erin, Jenna Voutsinas, Qian Wu, et al.. (2020). Patient-Reported Outcomes at Time of CAR-T Cell Therapy. Blood. 136(Supplement 1). 35–36. 4 indexed citations
5.
Mullane, Erin, Ana Cordeiro, Evandro D. Bezerra, et al.. (2019). Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy. Biology of Blood and Marrow Transplantation. 26(1). 34–43. 108 indexed citations
6.
Lee, Stephanie J., Barry E. Storer, Bronwen E. Shaw, et al.. (2018). Rates and Risk Factors for Post-Traumatic Stress Disorder Symptomatology among Adult Hematopoietic Cell Transplant Recipients and Their Informal Caregivers. Biology of Blood and Marrow Transplantation. 25(1). 145–150. 24 indexed citations
7.
Cordeiro, Ana, Evandro D. Bezerra, Joshua A. Hill, et al.. (2018). Late Effects of CD19-Targeted CAR-T Cell Therapy. Blood. 132(Supplement 1). 223–223. 11 indexed citations
8.
Zhou, Yi, Brent L. Wood, Roland B. Walter, et al.. (2017). Is there a need for morphologic exam to detect relapse in AML if multi-parameter flow cytometry is employed?. Leukemia. 31(11). 2536–2537. 6 indexed citations
9.
Chapuis, Aude G., Daniel Egan, Merav Bar, et al.. (2016). EBV-Specific Donor Cells Transduced to Express a High-Affinity WT1 TCR Can Prevent Recurrence in Post-HCT Patients with High-Risk AML. Blood. 128(22). 1001–1001. 6 indexed citations
10.
Jenkins, Isaac, Lynne P. Taylor, Raymond Farah, et al.. (2016). Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients. Bone Marrow Transplantation. 51(7). 973–979. 5 indexed citations
11.
Bar, Merav, Megan Othus, Vicky Sandhu, et al.. (2015). Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission. Leukemia & lymphoma. 56(11). 3109–3115. 12 indexed citations
12.
Bar, Merav, Weigang Tong, Megan Othus, Keith R. Loeb, & Elihu H. Estey. (2014). Central Nervous System Involvement in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(3). 546–551. 27 indexed citations
13.
Storer, Barry E., et al.. (2014). Metabolic Syndrome Appears Early After Hematopoietic Cell Transplantation. Metabolic Syndrome and Related Disorders. 12(7). 367–371. 8 indexed citations
14.
Chapuis, Aude G., Gunnar B. Ragnarsson, Hieu Nguyen, et al.. (2013). Transferred WT1-Reactive CD8 + T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients. Science Translational Medicine. 5(174). 174ra27–174ra27. 242 indexed citations
15.
Bar, Merav & Jerald P. Radich. (2013). Maintenance Therapy With Tyrosine Kinase Inhibitors After Transplant in Patients With Chronic Myeloid Leukemia. Journal of the National Comprehensive Cancer Network. 11(3). 308–315. 8 indexed citations
16.
Ware, Carol B., Linlin Wang, Brigham H. Mecham, et al.. (2009). Histone Deacetylase Inhibition Elicits an Evolutionarily Conserved Self-Renewal Program in Embryonic Stem Cells. Cell stem cell. 4(4). 359–369. 134 indexed citations
17.
Bar, Merav, Stacia K. Wyman, Brian R. Fritz, et al.. (2008). MicroRNA Discovery and Profiling in Human Embryonic Stem Cells by Deep Sequencing of Small RNA Libraries. Stem Cells. 26(10). 2496–2505. 247 indexed citations
18.
Bar, Merav, Claire Shannon‐Lowe, & Adam P. Geballe. (2001). Differentiation of Human Cytomegalovirus Genotypes in Immunocompromised Patients on the Basis of UL4 Gene Polymorphisms. The Journal of Infectious Diseases. 183(2). 218–225. 25 indexed citations
19.
Ahmed, Tauseef, R Kancherla, Zeeshan Qureshi, et al.. (2000). High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34+ selection to clinical outcome. Bone Marrow Transplantation. 25(10). 1041–1045. 5 indexed citations
20.
Bar, Merav, et al.. (1997). Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel‐Lindau and RET genes. Clinical Endocrinology. 47(6). 707–712. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan D. Fish Breakdown of academic impact, for papers by Qian Wu Breakdown of academic impact, for papers by Cecilia C.S. Yeung Breakdown of academic impact, for papers by Tim Sauer Breakdown of academic impact, for papers by Daria Pagliara Breakdown of academic impact, for papers by Manabu Kawakami Breakdown of academic impact, for papers by Rayne H. Rouce Breakdown of academic impact, for papers by Francesca Del Bufalo Breakdown of academic impact, for papers by Hai Cheng Breakdown of academic impact, for papers by Jordan Gauthier
Rankless by CCL
2026